EssexBio

Essex-Bio Group

简繁 EN

ANNOUNCEMENTS & SHAREHOLDER INFORMATION

Normative Disclosure, Honest Communication

Select category

ANNOUNCEMENTS SHAREHOLDER INFORMATION

Select time

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Date

Title

File

Times

2023-03-08

FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2022

1043

2023-03-08

ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022

1087

2023-03-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2023

1041

2023-02-24

NOTICE OF BOARD MEETING

1050

2023-02-22

UPDATE ON DISCLOSEABLE TRANSACTION AMENDMENT AGREEMENT TO THE CO-DEVELOPMENT LICENSE AGREEMENT WITH SHANGHAI HENLIUS BIOTECH, INC. FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION

1054

2023-02-10

VOLUNTARY ANNOUNCEMENT FIRST PATIENT FIRST DOSE COMPLETED IN THE UNITED STATES IN AN INTERNATIONAL MULTI-CENTRE PHASE 3 CLINICAL STUDY IN RELATION TO THE CO-DEVELOPMENT OF THE LICENSED PRODUCT WITH HENLIUS FOR THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION

1125

2023-02-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2023

1076

2023-01-10

1153

2023-01-04

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2022

1099

2022-12-29

NEXT DAY DISCLOSURE RETURN

1159

2022-12-21

NEXT DAY DISCLOSURE RETURN

1144

2022-12-02

NEXT DAY DISCLOSURE RETURN

1210

2022-12-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2022

1105

2022-12-01

NEXT DAY DISCLOSURE RETURN

1105

2022-11-30

NEXT DAY DISCLOSURE RETURN

1153

2022-11-28

NEXT DAY DISCLOSURE RETURN

1109

2022-11-25

NEXT DAY DISCLOSURE RETURN

1117

2022-11-24

NEXT DAY DISCLOSURE RETURN

1179

2022-11-23

NEXT DAY DISCLOSURE RETURN

1074

2022-11-22

NEXT DAY DISCLOSURE RETURN

1078

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT